| Literature DB >> 35625308 |
Angela De Palma1, Mirko Girolamo Cantatore1, Francesco Di Gennaro2, Francesca Signore1, Teodora Panza1, Debora Brascia1, Giulia De Iaco1, Doroty Sampietro1, Rosatea Quercia1, Marcella Genualdo1, Ondina Pizzuto1, Giuseppe Garofalo1, Fabio Signorile2, Davide Fiore Bavaro2, Gaetano Brindicci2, Nicolò De Gennaro2, Annalisa Saracino2, Nicola Antonio Adolfo Quaranta3, Gianfranco Favia4, Giuseppe Marulli1.
Abstract
Descending necrotizing mediastinitis (DNM) is an acute, rare, severe condition with high mortality, but the optimal management protocol is still controversial. We retrospectively analyzed the results of multidisciplinary management in patients treated for DNM at our center over the last twenty years. Fifteen male patients, mean age 49.07 ± 14.92 years, were treated: 9 with cervico-pharyngeal etiopathogenesis, 3 peri-tonsillar/tonsillar, 2 odontogenic, 1 post-surgical; 6 with DNM type I, 6 with type IIA, and 3 with type IIB (Endo's classification). Mean time between diagnosis and treatment was 2.24 ± 1.61 days. In all cases, mediastinum drainage via thoracotomy was performed after neck drainage via cervicotomy, associated with tooth treatment in two; one required re-operation; tracheostomy was necessary in 9, temporary intensive care unit stay in 4; 6 developed complications, without post-operative mortality. Main isolated germs were Staphylococci and Candida; 7 had polymicrobial infection. The most used antibiotics were meropenem, metronidazole, teicoplanin, third-generation cephalosporins and clyndamicin; anti-fungal drugs were fluconazole, caspofungin and anidulafungin. On multivariate analysis, presence of cardiovascular disease was statistically significantly associated with longer chest tube duration and hospital stay. DNM requires early diagnosis and treatment to reduce mortality and morbidity. The most effective treatment should provide a multidisciplinary approach, combining cervicotomy and thoracotomy to drain all infectious collections with administration and monitoring of the proper antimicrobial therapy.Entities:
Keywords: antibiotics; antimicrobial therapy; cervicotomy; descending necrotizing mediastinitis; early diagnosis; surgical treatment; thoracotomy
Year: 2022 PMID: 35625308 PMCID: PMC9137525 DOI: 10.3390/antibiotics11050664
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1CT scans showing the spread of infection of DNM in three of our patients, evaluated according to Endo’s classification of DNM [7,8]: (a) type I (DNM localized in the upper mediastinum above the tracheal bifurcation); (b) type IIA (DNM extends to the lower anterior mediastinum, below the tracheal bifurcation); (c) type IIB (DNM extends to the anterior and lower posterior mediastinum), with associated right pleural effusion. White arrows indicate the mediastinal involvement.
Figure 2In all cases, mediastinum drainage via thoracotomy was performed after neck drainage via cervicotomy: (a) intra-operative field during cervicotomy showing purulent material (white arrow) coming from the cervical fasciae; (b) intra-operative field during thoracotomy, showing yellowish purulent collection (white arrow) in the anterior mediastinum (the lung has been retracted).
Data relating to the continuous variables, expressed as mean ± standard deviation (s.d.).
| Continuous Variables | Mean ± S.D. |
|---|---|
| age (years) | 49.07 ± 14.92 |
| time between diagnosis and treatment (days) | 2.24 ± 1.61 |
| duration of thoracic surgery (minutes) | 130.63 ± 32.34 |
| duration of chest tubes (days) | 18.91 ± 13.46 |
| hospital stay (days) | 29.33 ± 14.24 |
| body mass index (BMI) | 23.94 ± 2.67 |
Figure 3Data relating to the nominal variables, expressed as percentages.
Data relating to the type of germs isolated on samples taken intra- or post-operatively (blood culture, bronchial lavage, pleural fluid) and antimicrobial post-operative therapy.
|
| ||
|
| ||
Multivariate analysis results for the risk of a worse course of DNM (p-value is reported, in bold when statistically significant).
| Diabetes | Overweight | Smoke/ | Cardiovascular | |
|---|---|---|---|---|
| tracheostomy | 0.273 | 0.586 | 0.361 | 0.805 |
| post-operative complications | 0.999 | 0.998 | 0.999 | 0.998 |
| type II DNM | 0.551 | 0.094 | 0.058 | 0.664 |
| chest tube duration > 19 days | 0.843 | 0.765 | 0.562 |
|
| hospital stay > 29 days | 0.424 | 0.621 | 0.869 |
|